Tonix Pharmaceuticals Announces Enrollment Initiated in the MGH Phase 2 ‘STROBE’…
Preliminary Data Show that Oxytocin Decreases Impulsivity and Reduces Food Intake TNX-1900 (Intranasal Potentiated Oxytocin) May Serve as a Novel Neuroendocrine Treatment for Binge-Eating…